KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Non-Current Debt (2016 - 2025)

Quest Diagnostics' Non-Current Debt history spans 17 years, with the latest figure at $5.2 billion for Q4 2025.

  • For Q4 2025, Non-Current Debt fell 7.98% year-over-year to $5.2 billion; the TTM value through Dec 2025 reached $5.2 billion, down 7.98%, while the annual FY2025 figure was $5.2 billion, 7.98% down from the prior year.
  • Non-Current Debt for Q4 2025 was $5.2 billion at Quest Diagnostics, roughly flat from $5.2 billion in the prior quarter.
  • Across five years, Non-Current Debt topped out at $5.9 billion in Q1 2025 and bottomed at $3.8 billion in Q2 2023.
  • The 5-year median for Non-Current Debt is $4.0 billion (2021), against an average of $4.4 billion.
  • The largest YoY upside for Non-Current Debt was 54.0% in 2025 against a maximum downside of 8.45% in 2025.
  • A 5-year view of Non-Current Debt shows it stood at $4.0 billion in 2021, then fell by 0.8% to $4.0 billion in 2022, then grew by 10.86% to $4.4 billion in 2023, then increased by 27.32% to $5.6 billion in 2024, then dropped by 7.98% to $5.2 billion in 2025.
  • Per Business Quant, the three most recent readings for DGX's Non-Current Debt are $5.2 billion (Q4 2025), $5.2 billion (Q3 2025), and $5.2 billion (Q2 2025).